121 related articles for article (PubMed ID: 37943051)
1. S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients.
Sanlav G; Baran B; Kum Özşengezer S; Kizmazoğlu D; Altun Z; Aktaş S; Olgun N
J Pediatr Hematol Oncol; 2024 Jan; 46(1):21-28. PubMed ID: 37943051
[TBL] [Abstract][Full Text] [Related]
2. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
4. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
5. A 3-Protein Expression Signature of Neuroblastoma for Outcome Prediction.
Xie Y; Xu H; Fang F; Li Z; Zhou H; Pan J; Guo W; Zhu X; Wang J; Wu Y
Am J Surg Pathol; 2018 Aug; 42(8):1027-1035. PubMed ID: 29794872
[TBL] [Abstract][Full Text] [Related]
6. Calreticulin expression in neuroblastoma--a novel independent prognostic factor.
Hsu WM; Hsieh FJ; Jeng YM; Kuo ML; Chen CN; Lai DM; Hsieh LJ; Wang BT; Tsao PN; Lee H; Lin MT; Lai HS; Chen WJ
Ann Oncol; 2005 Feb; 16(2):314-21. PubMed ID: 15668290
[TBL] [Abstract][Full Text] [Related]
7. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
8. Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.
Zhao X; Li D; Huang D; Song H; Mei H; Fang E; Wang X; Yang F; Zheng L; Huang K; Tong Q
Mol Ther; 2018 Mar; 26(3):755-773. PubMed ID: 29398485
[TBL] [Abstract][Full Text] [Related]
9. VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma.
Weng WC; Lin KH; Wu PY; Ho YH; Liu YL; Wang BJ; Chen CC; Lin YC; Liao YF; Lee WT; Hsu WM; Lee H
Sci Rep; 2017 Sep; 7(1):11212. PubMed ID: 28894229
[TBL] [Abstract][Full Text] [Related]
10. EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
Li Z; Takenobu H; Setyawati AN; Akita N; Haruta M; Satoh S; Shinno Y; Chikaraishi K; Mukae K; Akter J; Sugino RP; Nakazawa A; Nakagawara A; Aburatani H; Ohira M; Kamijo T
Oncogene; 2018 May; 37(20):2714-2727. PubMed ID: 29507419
[TBL] [Abstract][Full Text] [Related]
11. Calreticulin Regulates VEGF-A in Neuroblastoma Cells.
Weng WC; Lin KH; Wu PY; Lu YC; Weng YC; Wang BJ; Liao YF; Hsu WM; Lee WT; Lee H
Mol Neurobiol; 2015 Aug; 52(1):758-70. PubMed ID: 25288151
[TBL] [Abstract][Full Text] [Related]
12. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract][Full Text] [Related]
13. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract][Full Text] [Related]
14. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
15. Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma.
Sainero-Alcolado L; Mushtaq M; Liaño-Pons J; Rodriguez-Garcia A; Yuan Y; Liu T; Ruiz-Pérez MV; Schlisio S; Bedoya-Reina O; Arsenian-Henriksson M
J Exp Clin Cancer Res; 2022 Jul; 41(1):226. PubMed ID: 35850708
[TBL] [Abstract][Full Text] [Related]
16. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma.
Chang HH; Lee H; Hu MK; Tsao PN; Juan HF; Huang MC; Shih YY; Wang BJ; Jeng YM; Chang CL; Huang SF; Tsay YG; Hsieh FJ; Lin KH; Hsu WM; Liao YF
Clin Cancer Res; 2010 Sep; 16(17):4411-20. PubMed ID: 20736329
[TBL] [Abstract][Full Text] [Related]
17. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
[TBL] [Abstract][Full Text] [Related]
18. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract][Full Text] [Related]
19. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
20. Identification of neuroblastoma cell lines with uncommon TAZ
Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]